Martin Shkreli livestreamed violating lifetime pharmaceutical ban, FTC alleges

Martin Shkreli reportedly livestreamed himself violating a lifetime ban related to pharmaceutical activities, according to the Federal Trade Commission (FTC). During the livestream, Shkreli mentioned engaging with biotech stocks, which may relate to the alleged violation. This development highlights ongoing regulatory scrutiny of Shkreli's actions in the biotech and pharmaceutical sectors.

Originally published by arstechnica